**Prioritized Treatment Plan**

**1. Diagnostics**

ENG examination to evaluate vestibular function
- Source: RECOMMENDATIONS section, chunk_11:4648-5547
- Confidence: 0.9
- Risks/Benefits: None identified based on available information
- Hallucination Guard Note: None required

**2. Therapeutics**

1. Veramyst nasal spray, two sprays each nostril daily, with option for twice-daily use if symptoms worsen
- Source: RECOMMENDATIONS section, chunk_11:4648-5547
- Confidence: 0.9
- Risks/Benefits: None identified based on available information
- Hallucination Guard Note: None required

2. Medrol Dosepak as directed
- Source: RECOMMENDATIONS section, chunk_11:4648-5547
- Confidence: 0.9
- Risks/Benefits: None identified based on available information
- Hallucination Guard Note: None required

3. Clarinex 5 mg daily
- Source: RECOMMENDATIONS section, chunk_11:4648-5547
- Confidence: 0.9
- Risks/Benefits: None identified based on available information
- Hallucination Guard Note: None required

4. Nasal saline irrigation twice daily
- Source: RECOMMENDATIONS section, chunk_11:4648-5547
- Confidence: 0.9
- Risks/Benefits: None identified based on available information
- Hallucination Guard Note: None required

**3. Follow-ups**

None identified based on available information

Note: The confidence scores are based on the strength of evidence provided in the summary, and hallucination guard notes are included where necessary to highlight potential limitations or uncertainties in the recommendations.